Oncotelic Therapeutics' market value is the price at which a share of Oncotelic Therapeutics trades on a public exchange. It measures the collective expectations of Oncotelic Therapeutics investors about its performance. Oncotelic Therapeutics is trading at 0.08 as of the 2nd of January 2026, a 11.11 percent decrease since the beginning of the trading day. The stock's open price was 0.09. With this module, you can estimate the performance of a buy and hold strategy of Oncotelic Therapeutics and determine expected loss or profit from investing in Oncotelic Therapeutics over a given investment horizon. Check out Oncotelic Therapeutics Correlation, Oncotelic Therapeutics Volatility and Oncotelic Therapeutics Alpha and Beta module to complement your research on Oncotelic Therapeutics.
Please note, there is a significant difference between Oncotelic Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncotelic Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncotelic Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oncotelic Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oncotelic Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oncotelic Therapeutics.
0.00
10/04/2025
No Change 0.00
0.0
In 2 months and 31 days
01/02/2026
0.00
If you would invest 0.00 in Oncotelic Therapeutics on October 4, 2025 and sell it all today you would earn a total of 0.00 from holding Oncotelic Therapeutics or generate 0.0% return on investment in Oncotelic Therapeutics over 90 days. Oncotelic Therapeutics is related to or competes with Relief Therapeutics, Relief Therapeutics, Arch Biopartners, Covalon Technologies, Helix BioPharma, Cannabix Technologies, and Zivo Bioscience. Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment ... More
Oncotelic Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oncotelic Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oncotelic Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncotelic Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oncotelic Therapeutics' standard deviation. In reality, there are many statistical measures that can use Oncotelic Therapeutics historical prices to predict the future Oncotelic Therapeutics' volatility.
Oncotelic Therapeutics appears to be out of control, given 3 months investment horizon. Oncotelic Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0339, which implies the firm had a 0.0339 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Oncotelic Therapeutics, which you can use to evaluate the volatility of the company. Please evaluate Oncotelic Therapeutics' Semi Deviation of 4.8, risk adjusted performance of 0.0531, and Coefficient Of Variation of 1601.1 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Oncotelic Therapeutics holds a performance score of 2. The company holds a Beta of 0.5, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Oncotelic Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Oncotelic Therapeutics is expected to be smaller as well. Please check Oncotelic Therapeutics' information ratio, downside variance, day typical price, as well as the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Oncotelic Therapeutics' historical price patterns will revert.
Auto-correlation
0.20
Weak predictability
Oncotelic Therapeutics has weak predictability. Overlapping area represents the amount of predictability between Oncotelic Therapeutics time series from 4th of October 2025 to 18th of November 2025 and 18th of November 2025 to 2nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oncotelic Therapeutics price movement. The serial correlation of 0.2 indicates that over 20.0% of current Oncotelic Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.2
Spearman Rank Test
-0.32
Residual Average
0.0
Price Variance
0.0
Oncotelic Therapeutics lagged returns against current returns
Autocorrelation, which is Oncotelic Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oncotelic Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Oncotelic Therapeutics returns to help us make a trade decision. For example, suppose you find that Oncotelic Therapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Oncotelic Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oncotelic Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oncotelic Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oncotelic Therapeutics otc stock over time.
Current vs Lagged Prices
Timeline
Oncotelic Therapeutics Lagged Returns
When evaluating Oncotelic Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oncotelic Therapeutics otc stock have on its future price. Oncotelic Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oncotelic Therapeutics autocorrelation shows the relationship between Oncotelic Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Oncotelic Therapeutics.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Oncotelic OTC Stock
Oncotelic Therapeutics financial ratios help investors to determine whether Oncotelic OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncotelic with respect to the benefits of owning Oncotelic Therapeutics security.